Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

NCT00402766 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: Cisplatin
DRUG: Imatinib Mesylate
DRUG: Pemetrexed
DRUG: Dexamethasone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]